Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 105 entries
Sorted by: Best Match Show Resources per page
Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial.

Frontiers in pharmacology

Ridyard CH, Plumpton CO, Gilbert RE, Hughes DA.
PMID: 28974929
Front Pharmacol. 2017 Sep 19;8:644. doi: 10.3389/fphar.2017.00644. eCollection 2017.

No abstract available.

Cite
Ridyard CH, Plumpton CO, Gilbert RE, et al. Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Front Pharmacol. 2017;8:644doi: 10.3389/fphar.2017.00644.
Ridyard, C. H., Plumpton, C. O., Gilbert, R. E., & Hughes, D. A. (2017). Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Frontiers in pharmacology, 8644. https://doi.org/10.3389/fphar.2017.00644
Ridyard, Colin H, et al. "Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial." Frontiers in pharmacology vol. 8 (2017): 644. doi: https://doi.org/10.3389/fphar.2017.00644
Ridyard CH, Plumpton CO, Gilbert RE, Hughes DA. Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial. Front Pharmacol. 2017 Sep 19;8:644. doi: 10.3389/fphar.2017.00644. eCollection 2017. PMID: 28974929; PMCID: PMC5610787.
Copy Download .nbib Format: NLM
Controlling microbial contamination during hydrolysis of AFEX-pretreated corn stover and switchgrass: effects on hydrolysate composition, microbial response and fermentation.

Biotechnology for biofuels

Serate J, Xie D, Pohlmann E, Donald C, Shabani M, Hinchman L, Higbee A, Mcgee M, La Reau A, Klinger GE, Li S, Myers CL, Boone C, Bates DM, Cavalier D, Eilert D, Oates LG, Sanford G, Sato TK, Dale B, Landick R, Piotrowski J, Ong RG, Zhang Y.
PMID: 26583044
Biotechnol Biofuels. 2015 Nov 14;8:180. doi: 10.1186/s13068-015-0356-2. eCollection 2015.

BACKGROUND: Microbial conversion of lignocellulosic feedstocks into biofuels remains an attractive means to produce sustainable energy. It is essential to produce lignocellulosic hydrolysates in a consistent manner in order to study microbial performance in different feedstock hydrolysates. Because of...

Cite
Serate J, Xie D, Pohlmann E, et al. Controlling microbial contamination during hydrolysis of AFEX-pretreated corn stover and switchgrass: effects on hydrolysate composition, microbial response and fermentation. Biotechnol Biofuels. 2015;8:180doi: 10.1186/s13068-015-0356-2.
Serate, J., Xie, D., Pohlmann, E., Donald, C., Shabani, M., Hinchman, L., Higbee, A., Mcgee, M., La Reau, A., Klinger, G. E., Li, S., Myers, C. L., Boone, C., Bates, D. M., Cavalier, D., Eilert, D., Oates, L. G., Sanford, G., Sato, T. K., Dale, B., Landick, R., Piotrowski, J., Ong, R. G., & Zhang, Y. (2015). Controlling microbial contamination during hydrolysis of AFEX-pretreated corn stover and switchgrass: effects on hydrolysate composition, microbial response and fermentation. Biotechnology for biofuels, 8180. https://doi.org/10.1186/s13068-015-0356-2
Serate, Jose, et al. "Controlling microbial contamination during hydrolysis of AFEX-pretreated corn stover and switchgrass: effects on hydrolysate composition, microbial response and fermentation." Biotechnology for biofuels vol. 8 (2015): 180. doi: https://doi.org/10.1186/s13068-015-0356-2
Serate J, Xie D, Pohlmann E, Donald C, Shabani M, Hinchman L, Higbee A, Mcgee M, La Reau A, Klinger GE, Li S, Myers CL, Boone C, Bates DM, Cavalier D, Eilert D, Oates LG, Sanford G, Sato TK, Dale B, Landick R, Piotrowski J, Ong RG, Zhang Y. Controlling microbial contamination during hydrolysis of AFEX-pretreated corn stover and switchgrass: effects on hydrolysate composition, microbial response and fermentation. Biotechnol Biofuels. 2015 Nov 14;8:180. doi: 10.1186/s13068-015-0356-2. eCollection 2015. PMID: 26583044; PMCID: PMC4650398.
Copy Download .nbib Format: NLM
Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series.

Journal of clinical and investigative dermatology

Garcia D, Eilers RE, Jiang SB.
PMID: 28936478
J Clin Investig Dermatol. 2017 Feb;5(1). doi: 10.13188/2373-1044.1000037. Epub 2017 Feb 27.

BACKGROUND: Cutaneous melanoma is one of the fastest rising cancer diagnoses in recent years. Melanoma in situ (MIS) constitutes a large proportion of all diagnosed melanomas. While surgical excision is considered the standard of therapy, the literature is not...

Cite
Garcia D, Eilers RE, Jiang SB. Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series. J Clin Investig Dermatol. 2017;5(1)doi: 10.13188/2373-1044.1000037.
Garcia, D., Eilers, R. E., & Jiang, S. B. (2017). Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series. Journal of clinical and investigative dermatology, 5(1), . https://doi.org/10.13188/2373-1044.1000037
Garcia, Daniel, et al. "Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series." Journal of clinical and investigative dermatology vol. 5,1 (2017). doi: https://doi.org/10.13188/2373-1044.1000037
Garcia D, Eilers RE, Jiang SB. Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series. J Clin Investig Dermatol. 2017 Feb;5(1). doi: 10.13188/2373-1044.1000037. Epub 2017 Feb 27. PMID: 28936478; PMCID: PMC5603294.
Copy Download .nbib Format: NLM
Worldwide variations in artificial skyglow.

Scientific reports

Kyba CC, Tong KP, Bennie J, Birriel I, Birriel JJ, Cool A, Danielsen A, Davies TW, Outer PN, Edwards W, Ehlert R, Falchi F, Fischer J, Giacomelli A, Giubbilini F, Haaima M, Hesse C, Heygster G, Hölker F, Inger R, Jensen LJ, Kuechly HU, Kuehn J, Langill P, Lolkema DE, Nagy M, Nievas M, Ochi N, Popow E, Posch T, Puschnig J, Ruhtz T, Schmidt W, Schwarz R, Schwope A, Spoelstra H, Tekatch A, Trueblood M, Walker CE, Weber M, Welch DL, Zamorano J, Gaston KJ.
PMID: 25673335
Sci Rep. 2015 Feb 12;5:8409. doi: 10.1038/srep08409.

Despite constituting a widespread and significant environmental change, understanding of artificial nighttime skyglow is extremely limited. Until now, published monitoring studies have been local or regional in scope, and typically of short duration. In this first major international compilation...

Cite
Kyba CC, Tong KP, Bennie J, et al. Worldwide variations in artificial skyglow. Sci Rep. 2015;5:8409doi: 10.1038/srep08409.
Kyba, C. C., Tong, K. P., Bennie, J., Birriel, I., Birriel, J. J., Cool, A., Danielsen, A., Davies, T. W., Outer, P. N., Edwards, W., Ehlert, R., Falchi, F., Fischer, J., Giacomelli, A., Giubbilini, F., Haaima, M., Hesse, C., Heygster, G., Hölker, F., Inger, R., Jensen, L. J., Kuechly, H. U., Kuehn, J., Langill, P., Lolkema, D. E., Nagy, M., Nievas, M., Ochi, N., Popow, E., Posch, T., Puschnig, J., Ruhtz, T., Schmidt, W., Schwarz, R., Schwope, A., Spoelstra, H., Tekatch, A., Trueblood, M., Walker, C. E., Weber, M., Welch, D. L., Zamorano, J., & Gaston, K. J. (2015). Worldwide variations in artificial skyglow. Scientific reports, 58409. https://doi.org/10.1038/srep08409
Kyba, Christopher C M, et al. "Worldwide variations in artificial skyglow." Scientific reports vol. 5 (2015): 8409. doi: https://doi.org/10.1038/srep08409
Kyba CC, Tong KP, Bennie J, Birriel I, Birriel JJ, Cool A, Danielsen A, Davies TW, Outer PN, Edwards W, Ehlert R, Falchi F, Fischer J, Giacomelli A, Giubbilini F, Haaima M, Hesse C, Heygster G, Hölker F, Inger R, Jensen LJ, Kuechly HU, Kuehn J, Langill P, Lolkema DE, Nagy M, Nievas M, Ochi N, Popow E, Posch T, Puschnig J, Ruhtz T, Schmidt W, Schwarz R, Schwope A, Spoelstra H, Tekatch A, Trueblood M, Walker CE, Weber M, Welch DL, Zamorano J, Gaston KJ. Worldwide variations in artificial skyglow. Sci Rep. 2015 Feb 12;5:8409. doi: 10.1038/srep08409. PMID: 25673335; PMCID: PMC5389131.
Copy Download .nbib Format: NLM
Adenosine induces growth-cone turning of sensory neurons.

Purinergic signalling

Grau B, Eilert JC, Munck S, Harz H.
PMID: 18777107
Purinergic Signal. 2008 Dec;4(4):357-64. doi: 10.1007/s11302-008-9121-3. Epub 2008 Sep 06.

The formation of appropriate connections between neurons and their specific targets is an essential step during development and repair of the nervous system. Growth cones are located at the leading edges of the growing neurites and respond to environmental...

Cite
Grau B, Eilert JC, Munck S, et al. Adenosine induces growth-cone turning of sensory neurons. Purinergic Signal. 2008;4(4):357-64doi: 10.1007/s11302-008-9121-3.
Grau, B., Eilert, J. C., Munck, S., & Harz, H. (2008). Adenosine induces growth-cone turning of sensory neurons. Purinergic signalling, 4(4), 357-64. https://doi.org/10.1007/s11302-008-9121-3
Grau, Benjamin, et al. "Adenosine induces growth-cone turning of sensory neurons." Purinergic signalling vol. 4,4 (2008): 357-64. doi: https://doi.org/10.1007/s11302-008-9121-3
Grau B, Eilert JC, Munck S, Harz H. Adenosine induces growth-cone turning of sensory neurons. Purinergic Signal. 2008 Dec;4(4):357-64. doi: 10.1007/s11302-008-9121-3. Epub 2008 Sep 06. PMID: 18777107; PMCID: PMC2583205.
Copy Download .nbib Format: NLM
Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara.

Plant cell reports

Emke A, Eilert U.
PMID: 24247961
Plant Cell Rep. 1986 Feb;5(1):31-4. doi: 10.1007/BF00269712.

Callus and cell suspension cultures were established with shoots of the soladulcidine variety of the bittersweet Solanum dulcamara L. Plantlets were regenerated from undifferentiated callus. From mixotrophic callus as well as mixotrophic suspension cultures soladulicidine, solasodine and the corresponding...

Cite
Emke A, Eilert U. Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant Cell Rep. 1986;5(1):31-4doi: 10.1007/BF00269712.
Emke, A., & Eilert, U. (1986). Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant cell reports, 5(1), 31-4. https://doi.org/10.1007/BF00269712
Emke, A, and Eilert, U. "Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara." Plant cell reports vol. 5,1 (1986): 31-4. doi: https://doi.org/10.1007/BF00269712
Emke A, Eilert U. Steroidal alkaloids in tissue cultures and regenerated plants of Solanum dulcamara. Plant Cell Rep. 1986 Feb;5(1):31-4. doi: 10.1007/BF00269712. PMID: 24247961.
Copy Download .nbib Format: NLM
Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy.

Nephron extra

Chen LH, Stead B, Advani SL, Yaqoob N, Thai K, Kabir MG, Yuen DA, Connelly KA, Gilbert RE, Advani A.
PMID: 22739500
Nephron Extra. 2012 Jan;2(1):115-24. doi: 10.1159/000338272. Epub 2012 May 12.

UNLABELLED: BACKGROUND/AIMSBACKGROUND/AIMS: While experimental models that emulate diabetic nephropathy are valuable tools for elucidating pathogenetic mechanisms and developing novel therapies, existing models imperfectly recapitulate human disease. In diabetes, hyperglycemia and hemodynamic forces act in concert to induce renal injury....

Cite
Chen LH, Stead B, Advani SL, et al. Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy. Nephron Extra. 2012;2(1):115-24doi: 10.1159/000338272.
Chen, L. H., Stead, B., Advani, S. L., Yaqoob, N., Thai, K., Kabir, M. G., Yuen, D. A., Connelly, K. A., Gilbert, R. E., & Advani, A. (2012). Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy. Nephron extra, 2(1), 115-24. https://doi.org/10.1159/000338272
Chen, Li-Hao, et al. "Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy." Nephron extra vol. 2,1 (2012): 115-24. doi: https://doi.org/10.1159/000338272
Chen LH, Stead B, Advani SL, Yaqoob N, Thai K, Kabir MG, Yuen DA, Connelly KA, Gilbert RE, Advani A. Hyperglycemia and renal mass ablation synergistically augment albuminuria in the diabetic subtotally nephrectomized rat: implications for modeling diabetic nephropathy. Nephron Extra. 2012 Jan;2(1):115-24. doi: 10.1159/000338272. Epub 2012 May 12. PMID: 22739500; PMCID: PMC3383305.
Copy Download .nbib Format: NLM
The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Opingari E, Verma S, Connelly KA, Mazer CD, Teoh H, Quan A, Zuo F, Pan Y, Bhatt DL, Zinman B, Leiter LA, Yan AT, Cherney DZI, Gilbert RE.
PMID: 32159783
Nephrol Dial Transplant. 2020 May 01;35(5):895-897. doi: 10.1093/ndt/gfz294.

No abstract available.

Cite
Opingari E, Verma S, Connelly KA, et al. The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial. Nephrol Dial Transplant. 2020;35(5):895-897doi: 10.1093/ndt/gfz294.
Opingari, E., Verma, S., Connelly, K. A., Mazer, C. D., Teoh, H., Quan, A., Zuo, F., Pan, Y., Bhatt, D. L., Zinman, B., Leiter, L. A., Yan, A. T., Cherney, D. Z. I., & Gilbert, R. E. (2020). The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 35(5), 895-897. https://doi.org/10.1093/ndt/gfz294
Opingari, Erika, et al. "The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 35,5 (2020): 895-897. doi: https://doi.org/10.1093/ndt/gfz294
Opingari E, Verma S, Connelly KA, Mazer CD, Teoh H, Quan A, Zuo F, Pan Y, Bhatt DL, Zinman B, Leiter LA, Yan AT, Cherney DZI, Gilbert RE. The impact of empagliflozin on kidney injury molecule-1: a subanalysis of the Effects of Empagliflozin on Cardiac Structure, Function, and Circulating Biomarkers in Patients with Type 2 Diabetes CardioLink-6 trial. Nephrol Dial Transplant. 2020 May 01;35(5):895-897. doi: 10.1093/ndt/gfz294. PMID: 32159783.
Copy Download .nbib Format: NLM
Atom-specific activation in CO oxidation.

The Journal of chemical physics

Schreck S, Diesen E, LaRue J, Ogasawara H, Marks K, Nordlund D, Weston M, Beye M, Cavalca F, Perakis F, Sellberg J, Eilert A, Kim KH, Coslovich G, Coffee R, Krzywinski J, Reid A, Moeller S, Lutman A, Öström H, Pettersson LGM, Nilsson A.
PMID: 30579301
J Chem Phys. 2018 Dec 21;149(23):234707. doi: 10.1063/1.5044579.

We report on atom-specific activation of CO oxidation on Ru(0001) via resonant X-ray excitation. We show that resonant 1

Cite
Schreck S, Diesen E, LaRue J, et al. Atom-specific activation in CO oxidation. J Chem Phys. 2018;149(23):234707doi: 10.1063/1.5044579.
Schreck, S., Diesen, E., LaRue, J., Ogasawara, H., Marks, K., Nordlund, D., Weston, M., Beye, M., Cavalca, F., Perakis, F., Sellberg, J., Eilert, A., Kim, K. H., Coslovich, G., Coffee, R., Krzywinski, J., Reid, A., Moeller, S., Lutman, A., Öström, H., Pettersson, L. G. M., & Nilsson, A. (2018). Atom-specific activation in CO oxidation. The Journal of chemical physics, 149(23), 234707. https://doi.org/10.1063/1.5044579
Schreck, Simon, et al. "Atom-specific activation in CO oxidation." The Journal of chemical physics vol. 149,23 (2018): 234707. doi: https://doi.org/10.1063/1.5044579
Schreck S, Diesen E, LaRue J, Ogasawara H, Marks K, Nordlund D, Weston M, Beye M, Cavalca F, Perakis F, Sellberg J, Eilert A, Kim KH, Coslovich G, Coffee R, Krzywinski J, Reid A, Moeller S, Lutman A, Öström H, Pettersson LGM, Nilsson A. Atom-specific activation in CO oxidation. J Chem Phys. 2018 Dec 21;149(23):234707. doi: 10.1063/1.5044579. PMID: 30579301.
Copy Download .nbib Format: NLM
Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs.

Molecular therapy. Methods & clinical development

Spronck EA, Liu YP, Lubelski J, Ehlert E, Gielen S, Montenegro-Miranda P, de Haan M, Nijmeijer B, Ferreira V, Petry H, van Deventer SJ.
PMID: 31709273
Mol Ther Methods Clin Dev. 2019 Sep 26;15:221-231. doi: 10.1016/j.omtm.2019.09.005. eCollection 2019 Dec 13.

Gene therapy for severe hemophilia B is advancing and offers sustained disease amelioration with a single treatment. We have reported the efficacy and safety of AMT-060, an investigational gene therapy comprising an adeno-associated virus serotype 5 capsid encapsidating the...

Cite
Spronck EA, Liu YP, Lubelski J, et al. Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs. Mol Ther Methods Clin Dev. 2019;15:221-231doi: 10.1016/j.omtm.2019.09.005.
Spronck, E. A., Liu, Y. P., Lubelski, J., Ehlert, E., Gielen, S., Montenegro-Miranda, P., de Haan, M., Nijmeijer, B., Ferreira, V., Petry, H., & van Deventer, S. J. (2019). Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs. Molecular therapy. Methods & clinical development, 15221-231. https://doi.org/10.1016/j.omtm.2019.09.005
Spronck, Elisabeth A, et al. "Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs." Molecular therapy. Methods & clinical development vol. 15 (2019): 221-231. doi: https://doi.org/10.1016/j.omtm.2019.09.005
Spronck EA, Liu YP, Lubelski J, Ehlert E, Gielen S, Montenegro-Miranda P, de Haan M, Nijmeijer B, Ferreira V, Petry H, van Deventer SJ. Enhanced Factor IX Activity following Administration of AAV5-R338L "Padua" Factor IX versus AAV5 WT Human Factor IX in NHPs. Mol Ther Methods Clin Dev. 2019 Sep 26;15:221-231. doi: 10.1016/j.omtm.2019.09.005. eCollection 2019 Dec 13. PMID: 31709273; PMCID: PMC6834974.
Copy Download .nbib Format: NLM
Electron-energy-loss study of clean and oxygen-exposed polycrystalline zirconium.

Physical review. B, Condensed matter

Asbury DA, Corallo GR, Gilbert RE, Hoflund GB.
PMID: 9941369
Phys Rev B Condens Matter. 1987 Jun 15;35(18):9451-9459. doi: 10.1103/physrevb.35.9451.

No abstract available.

Cite
Asbury DA, Corallo GR, Gilbert RE, et al. Electron-energy-loss study of clean and oxygen-exposed polycrystalline zirconium. Phys Rev B Condens Matter. 1987;35(18):9451-9459doi: 10.1103/physrevb.35.9451.
Asbury, D. A., Corallo, G. R., Gilbert, R. E., & Hoflund, G. B. (1987). Electron-energy-loss study of clean and oxygen-exposed polycrystalline zirconium. Physical review. B, Condensed matter, 35(18), 9451-9459. https://doi.org/10.1103/physrevb.35.9451
Asbury, et al. "Electron-energy-loss study of clean and oxygen-exposed polycrystalline zirconium." Physical review. B, Condensed matter vol. 35,18 (1987): 9451-9459. doi: https://doi.org/10.1103/physrevb.35.9451
Asbury DA, Corallo GR, Gilbert RE, Hoflund GB. Electron-energy-loss study of clean and oxygen-exposed polycrystalline zirconium. Phys Rev B Condens Matter. 1987 Jun 15;35(18):9451-9459. doi: 10.1103/physrevb.35.9451. PMID: 9941369.
Copy Download .nbib Format: NLM
Factors influencing utilization of cancer rehabilitation services among older breast cancer survivors in the USA: a qualitative study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Brick R, Lyons KD, Bender C, Eilers R, Ferguson R, Pergolotti M, Toto P, Skidmore E, Leland NE.
PMID: 34766199
Support Care Cancer. 2021 Nov 11; doi: 10.1007/s00520-021-06678-9. Epub 2021 Nov 11.

PURPOSE: Many older breast cancer survivors experience long-term disability due to cancer and cancer-related treatments. However, less than 20% of older breast cancer survivors utilize cancer rehabilitation services to address cancer-related disability. Further understanding of survivor experiences may reveal...

Cite
Brick R, Lyons KD, Bender C, et al. Factors influencing utilization of cancer rehabilitation services among older breast cancer survivors in the USA: a qualitative study. Support Care Cancer. 2021;doi: 10.1007/s00520-021-06678-9.
Brick, R., Lyons, K. D., Bender, C., Eilers, R., Ferguson, R., Pergolotti, M., Toto, P., Skidmore, E., & Leland, N. E. (2021). Factors influencing utilization of cancer rehabilitation services among older breast cancer survivors in the USA: a qualitative study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, . https://doi.org/10.1007/s00520-021-06678-9
Brick, Rachelle, et al. "Factors influencing utilization of cancer rehabilitation services among older breast cancer survivors in the USA: a qualitative study." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. (2021). doi: https://doi.org/10.1007/s00520-021-06678-9
Brick R, Lyons KD, Bender C, Eilers R, Ferguson R, Pergolotti M, Toto P, Skidmore E, Leland NE. Factors influencing utilization of cancer rehabilitation services among older breast cancer survivors in the USA: a qualitative study. Support Care Cancer. 2021 Nov 11; doi: 10.1007/s00520-021-06678-9. Epub 2021 Nov 11. PMID: 34766199.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 105 entries